Exclusive

Publication

Byline

Location

US Patent Issued on Oct. 27 for "Synergistic herbal compositions for pain management and opioid use reduction" (Texas Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,440, issued on Oct. 27. "Synergistic herbal compositions for pain management and opioid use reduction" was invented by Jeffrey L. Pfohl (Sa... Read More


US Patent Issued to Sepsia Therapeutics on Oct. 27 for "Bacterial-binding peptides for treatment of infectious diseases and related inflammatory processes" (Spanish Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,441, issued on Oct. 27, was assigned to Sepsia Therapeutics S.L. (L'hospitalet de Llobergat, Spain). "Bacterial-binding peptides for treatm... Read More


US Patent Issued to THE BROAD INSTITUTE, Massachusetts Institute of Technology on Oct. 27 for "Ultra-sensitive step-function opsin for minimally invasive optogenetic stimulation" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,442, issued on Oct. 27, was assigned to THE BROAD INSTITUTE INC. (Cambridge, Mass.) and Massachusetts Institute of Technology (Cambridge, Ma... Read More


US Patent Issued to Gan & Lee Pharmaceuticals on Oct. 27 for "Insulin derivative" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,443, issued on Oct. 27, was assigned to Gan & Lee Pharmaceuticals Co. Ltd. (Beijing). "Insulin derivative" was invented by Zhongru Gan (Bei... Read More


US Patent Issued to Gdanski Uniwersytet Medyczny on Oct. 27 for "Therapeutic vaccine for treatment of diabetes type 1 in children, application of the cell sorter and the method of multiplying Treg cells to produce therapeutic vaccine for treatment of diabetes type 1" (Polish Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,444, issued on Oct. 27, was assigned to Gdanski Uniwersytet Medyczny (Gdansk, Poland). "Therapeutic vaccine for treatment of diabetes type ... Read More


US Patent Issued to Health Research on Oct. 27 for "Major histocompatibility complex class II-expressing cancer cell vaccine and methods of use for producing integrated immune responses" (New York Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,445, issued on Oct. 27, was assigned to Health Research Inc. (Buffalo, N.Y.). "Major histocompatibility complex class II-expressing cancer ... Read More


US Patent Issued to STEMCELL TECHNOLOGIES CANADA on Oct. 27 for "Methods to stimulate immune responses to mutant Ras using nucleated cells" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,446, issued on Oct. 27, was assigned to STEMCELL TECHNOLOGIES CANADA INC. (Vancouver, Canada). "Methods to stimulate immune responses to mu... Read More


US Patent Issued to Pfizer on Oct. 27 for "Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof" (North Carolina, New York, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,447, issued on Oct. 27, was assigned to Pfizer Inc. (New York). "Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and ... Read More


US Patent Issued to Merck Sharp & Dohme on Oct. 27 for "Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,448, issued on Oct. 27, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "Compositions comprising Streptococcus pneumoniae polysacch... Read More


US Patent Issued to The Catholic University of America on Oct. 27 for "Bacteriophage-based, needle and adjuvant-free, mucosal COVID-19 vaccine" (District Of Columbia Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,449, issued on Oct. 27, was assigned to The Catholic University of America (Washington). "Bacteriophage-based, needle and adjuvant-free, mu... Read More